Join
Live feed
·
INSIDERFilingvia Quantisnow
Mersana Therapeutics Inc. logo

VP, Chief Accounting Officer Mandelia Ashish sold $16,298 worth of shares (8,216 units at $1.98) and converted options into 30,000 shares, increasing direct ownership by 84% to 47,757 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRSN (Mersana Therapeutics Inc.) and more on Quantisnow.